Zeria Pharmaceutical Co., Ltd. (TYO:4559)

Zeria Pharmaceutical Revenue

Zeria Pharmaceutical had revenue of 21.45B JPY in the quarter ending June 30, 2026, with 10.05% growth. This brings the company's total for the last twelve months to 91.12B, up 6.76% year-over-year. In the fiscal year ending March 31, 2026, Zeria Pharmaceutical had annual revenue of 89.16B with 2.12% growth. That makes Zeria Pharmaceutical the 10,403rd largest company in the world by revenue and 1,085th in Japan.

• Revenue (ttm): 91.12B
• Revenue Growth: +6.76%
• P/S Ratio: 0.98
• Revenue / Employee: 52.13M
• Employees: 1,748
• Market Cap: 89.22B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Ethical Pharmaceutical Business 61.63B 68.8%
• Consumer Health Care Business 27.38B 30.5%
• Other 628.72M 0.7%

By Geography

Chart

• Japan 36.32B 40.7%
• Other Europe 24.01B 26.9%
• UK 12.41B 13.9%
• France 10.17B 11.4%
• Other 6.26B 7.0%

Fiscal year ended Mar 31, 2026 See the full Zeria Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	89.16B	1.85B	2.12%
Mar 31, 2025	87.31B	11.59B	15.30%
Mar 31, 2024	75.73B	7.34B	10.74%
Mar 31, 2023	68.38B	8.85B	14.87%
Mar 31, 2022	59.53B	4.09B	7.38%

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error